IGMS IGM Biosciences, Inc. Stock Quote

IGMS [NASD]

Index	-	P/E	-	EPS (ttm)	-5.51	Insider Own	1.10%	Shs Outstand	33.92M	Perf Week	-5.27%
Market Cap	636.61M	Forward P/E	-	EPS next Y	-5.73	Insider Trans	19.81%	Shs Float	16.19M	Perf Month	-6.01%
Income	-185.40M	PEG	-	EPS next Q	-1.61	Inst Own	67.80%	Short Float	21.66%	Perf Quarter	-2.86%
Sales	-	P/S	-	EPS this Y	-86.50%	Inst Trans	2.23%	Short Ratio	2.86	Perf Half Y	-70.80%
Book/sh	6.03	P/B	2.59	EPS next Y	-2.10%	ROA	-59.90%	Target Price	51.22	Perf Year	-78.65%
Cash/sh	4.60	P/C	3.40	EPS next 5Y	-	ROE	-70.10%	52W Range	12.74 - 99.44	Perf YTD	-46.71%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-84.28%	Beta	-
Dividend %	-	Quick Ratio	7.20	Sales past 5Y	-	Gross Margin	-	52W Low	22.66%	ATR	1.84
Employees	216	Current Ratio	7.20	Sales Q/Q	-	Oper. Margin	-	RSI (14)	44.41	Volatility	11.56% 11.87%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-61.10%	Profit Margin	-	Rel Volume	0.32	Prev Close	17.37
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 09 AMC	Payout	-	Avg Volume	1.23M	Price	15.63
Recom	1.70	SMA20	-7.29%	SMA50	-15.36%	SMA200	-59.52%	Volume	392,794	Change	-10.02%

Dec-13-21

Downgrade

RBC Capital Mkts

Outperform → Sector Perform

$51

Nov-05-21

Upgrade

Wedbush

Neutral → Outperform

Aug-26-21

Initiated

Morgan Stanley

Overweight

$100

Jan-29-21

Initiated

RBC Capital Mkts

Outperform

$121

Jan-19-21

Reiterated

H.C. Wainwright

Buy

$88 → $114

Dec-22-20

Downgrade

Wedbush

Outperform → Neutral

Jul-17-20

Initiated

Robert W. Baird

Outperform

$90

Jul-01-20

Initiated

H.C. Wainwright

Buy

$88

May-28-20

Initiated

SunTrust

Buy

$86

Apr-22-20

Initiated

Wedbush

Outperform

$73

Oct-14-19

Initiated

Stifel

Buy

$32

Oct-14-19

Initiated

Piper Jaffray

Overweight

$26

Oct-14-19

Initiated

Jefferies

Buy

$25

Oct-14-19

Initiated

Guggenheim

Buy

$30

May-20-22 12:07PM	We're Keeping An Eye On IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate Simply Wall St.
May-10-22 07:00AM	IGM Biosciences to Present at the 2022 RBC Capital Markets Global Healthcare Conference GlobeNewswire +5.34%
May-09-22 04:16PM	IGM Biosciences Announces First Quarter 2022 Financial Results and Provides Corporate Update GlobeNewswire -12.23%
May-06-22 07:00AM	IGM Biosciences Announces Closing of Global Collaboration Agreement with Sanofi GlobeNewswire
Apr-09-22 09:35AM	Nielsen, IGM Biosciences, and, Yes, Twitter, See Action From Activist Investors Barrons.com
Apr-06-22 04:39PM	IGM Announces Closing of $230.0 Million Public Offering GlobeNewswire +8.33%
Apr-05-22 04:56PM	What Kind Of Investors Own Most Of IGM Biosciences, Inc. (NASDAQ:IGMS)? Simply Wall St.
Mar-30-22 03:06PM	Why Did Truist Lower IGM Biosciences' Price Target? Benzinga -12.34%
02:14PM	Is IGM Biosciences Stock a Buy Following Sanofi Deal Surge? RBC Weighs In TipRanks
01:29PM	Biotech Stock Roundup: AXSM to Acquire JAZZ's Drug, IGMS Up on SNY Deal & More Zacks
11:57AM	IGM (IGMS) Skyrockets on Collaboration Deal With Sanofi Zacks
12:56AM	IGM Announces Pricing of $200.0 Million Public Offering GlobeNewswire
Mar-29-22 11:41AM	Why IGM Biosciences Stock Rocketed Higher Today Motley Fool +96.73%
09:00AM	These 2 Stocks Are Up 20%-Plus in Tuesday's Premarket Motley Fool
08:54AM	IGM Biosciences Shares Rise on Collaboration Agreement with Sanofi Investing.com
07:59AM	Midday Stock Movers: Nielsen, Robinhood, IGM Biosciences Rise Investing.com
07:41AM	IGM Announces Proposed Public Offering GlobeNewswire
06:01AM	IGM Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update GlobeNewswire
02:00AM	IGM Biosciences to Host Conference Call and Webcast Today to Discuss Global Collaboration Agreement with Sanofi GlobeNewswire
Feb-09-22 03:34PM	Why Did IGM Biosciences Shares Advance Today? Benzinga +9.35%
07:00AM	IGM Biosciences Advances Novel Antibody IGM-6268 Into Clinical Trials for the Treatment and Prevention of COVID-19 GlobeNewswire
Feb-03-22 04:05PM	IGM Biosciences to Present at the Guggenheim 2022 Oncology Conference GlobeNewswire
Jan-10-22 10:00AM	Here's Why IGM Biosciences, Inc. (IGMS) is Poised for a Turnaround After Losing 50.6% in 4 Weeks Zacks
Jan-05-22 07:00AM	IGM Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference GlobeNewswire -5.66%
Dec-13-21 09:43AM	IGM Biosciences' B Cell Malignancies Trial Data Fails To Lift The Stock Benzinga -41.31%
07:08AM	IGM Biosciences Stock Plunges After Downgrade on Trial Data Investing.com
Dec-11-21 01:31PM	IGM Biosciences Presents Clinical Data from IGM-2323 in Patients with Advanced B Cell Malignancies at 2021 American Society of Hematology Annual Meeting GlobeNewswire
Dec-09-21 07:36AM	Recent gains in IGM Biosciences, Inc. (NASDAQ:IGMS) help add back some value on insider purchases worth US$4.0m, still down US$1.7m Simply Wall St.
Dec-08-21 07:00AM	IGM Biosciences to Collaborate on the Study of IgM and IgA Antibodies for the Prevention of Malaria GlobeNewswire
Dec-06-21 04:05PM	IGM Biosciences to Host Conference Call and Webcast to Review IGM-2323 Data Presented at the 63rd Annual ASH Meeting GlobeNewswire
Nov-10-21 04:05PM	IGM Biosciences to Present at the Jefferies London Healthcare Conference GlobeNewswire
11:15AM	Were Hedge Funds Right About Dumping IGM Biosciences, Inc. (IGMS)? Insider Monkey
Nov-08-21 07:00AM	IGM Biosciences to Present at the Stifel 2021 Virtual Healthcare Conference GlobeNewswire
Nov-04-21 11:25AM	Notable Igm Biosciences Insider Trades $130K In Company Stock Benzinga
09:21AM	IGM Biosciences Announces Third Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire
Oct-11-21 04:05PM	IGM Biosciences Announces Leadership Appointments and Formation of IGM Infectious Diseases and IGM Autoimmunity and Inflammation Business Units GlobeNewswire
Oct-06-21 11:44AM	Notable Igm Biosciences Insider Trades $165K In Company Stock Benzinga -9.29%
Sep-23-21 04:05PM	IGM Biosciences to Present at the 2021 Cantor Virtual Global Healthcare Conference GlobeNewswire
Sep-10-21 09:01AM	IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans Simply Wall St.
Sep-07-21 07:00AM	IGM Biosciences to Participate in Three Upcoming Investor Conferences GlobeNewswire
Aug-09-21 04:06PM	IGM Biosciences Announces Second Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire +5.84%
Jul-29-21 05:31PM	IGM Biosciences Announces the Appointment of Chris H. Takimoto, M.D., Ph.D., F.A.C.P., as Chief Medical Officer GlobeNewswire
Jul-26-21 08:17PM	Were Hedge Funds Right About Piling Into IGM Biosciences, Inc. (IGMS)? Insider Monkey
Jun-12-21 05:05AM	Have Insiders Been Buying IGM Biosciences, Inc. (NASDAQ:IGMS) Shares? Simply Wall St.
Jun-03-21 07:01AM	IGM Biosciences Announces Expansion of IgM Platform into Infectious Diseases, Publication of Preclinical Data in Nature Demonstrating Engineered IgM Antibody Antiviral Activity for the Treatment and Prevention of COVID-19 GlobeNewswire +8.74%
May-26-21 07:00AM	IGM Biosciences to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire +6.36%
May-12-21 07:00AM	IGM Biosciences to Present at the 2021 RBC Capital Markets Global Healthcare Conference GlobeNewswire
May-03-21 08:02AM	MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for Shareholders GlobeNewswire
Apr-27-21 07:00AM	IGM Biosciences to Present at the Truist Securities Life Sciences Summit GlobeNewswire
Apr-12-21 07:00AM	IGM Biosciences Appoints George Gauthier as Chief Commercial Officer GlobeNewswire -9.33%
Mar-30-21 04:17PM	IGM Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM	IGM Biosciences Inc to Host Earnings Call ACCESSWIRE
Mar-24-21 07:00AM	IGM Biosciences to Announce Fourth Quarter and Year-end 2020 Financial Results and Host Conference Call and Webcast on March 30, 2021 GlobeNewswire -11.57%
Mar-15-21 07:00AM	IGM Biosciences Appoints Lisa Decker, Ph.D., as Chief Business Officer GlobeNewswire
Mar-14-21 05:52AM	IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans Simply Wall St.
Mar-08-21 09:51AM	5 Value Stocks In The Healthcare Sector Benzinga -8.57%
Feb-05-21 07:00AM	IGM Biosciences to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day GlobeNewswire +5.14%
Jan-12-21 08:15AM	The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue Benzinga +6.80%
Jan-11-21 06:00PM	IGM Biosciences Enters into Exclusive Licensing Agreement with Medivir for Birinapant GlobeNewswire
Jan-07-21 07:00AM	IGM Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-23-20 10:32AM	Here Are the 2 Best Biotech Stocks in This Multibillion-Dollar Industry Motley Fool
Dec-21-20 10:45AM	This Biotech Skyrocketed 84% in 2 Days, But Is It Warranted? Motley Fool
Dec-17-20 01:43PM	Is IGMS A Good Stock To Buy Now? Insider Monkey
Dec-14-20 01:52AM	Have Insiders Been Buying IGM Biosciences, Inc. (NASDAQ:IGMS) Shares? Simply Wall St.
Dec-11-20 04:05PM	IGM Announces Closing of $230 Million Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire -8.76%
Dec-08-20 10:30PM	IGM Announces Pricing of Upsized $200 million Public Offering GlobeNewswire +57.75%
Dec-07-20 05:07PM	IGM Announces Proposed Public Offering GlobeNewswire +16.56%
Dec-05-20 01:30PM	IGM Biosciences Presents First Clinical Data from IGM-2323 in Non-Hodgkins Lymphoma at 2020 ASH Annual Meeting GlobeNewswire
Nov-30-20 07:00AM	IGM Biosciences to Host Conference Call and Webcast to Review IGM-2323 Data Presented at the 62nd Annual ASH Meeting GlobeNewswire
Nov-23-20 07:00AM	IGM Biosciences to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference GlobeNewswire
Nov-16-20 09:48AM	A Look Into Healthcare Sector Value Stocks Benzinga
Nov-09-20 07:00AM	IGM Biosciences to Present at Three Upcoming Investor Conferences GlobeNewswire +14.22%
Nov-05-20 07:02AM	IGM Biosciences Announces Third Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
Nov-04-20 09:20AM	IGM Biosciences to Present First Clinical Data from IGM-2323 in Non-Hodgkins Lymphoma at 2020 ASH Annual Meeting GlobeNewswire -6.67%
Sep-30-20 07:00AM	IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-8444 for the Treatment of Solid Cancers and Non-Hodgkins Lymphoma GlobeNewswire
Sep-24-20 04:01PM	AbCellera and IGM Biosciences Announce Multi-Year Antibody Discovery Collaboration GlobeNewswire -5.41%
Sep-18-20 06:51PM	Scientific Games and Cracker Barrel See Activist Action Barrons.com +17.91%
Sep-16-20 09:00AM	IGM Biosciences (IGMS) Catches Eye: Stock Jumps 8.7% Zacks
Sep-14-20 12:04PM	Here's Why We're Not Too Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation Simply Wall St. +11.12%
Sep-02-20 07:00AM	IGM Biosciences to Present at Four Upcoming Investor Conferences GlobeNewswire +6.57%
Aug-06-20 04:08PM	IGM Biosciences Announces Second Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire -5.03%
Aug-04-20 07:00AM	IGM Biosciences to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference GlobeNewswire
Jun-28-20 05:58PM	Hedge Funds Getting Bullish On IGM Biosciences, Inc. (IGMS) Insider Monkey
Jun-16-20 06:27AM	IGM Biosciences, Inc. (NASDAQ:IGMS) Insiders Increased Their Holdings Simply Wall St.
May-28-20 07:00AM	IGM Biosciences to Present at the Jefferies 2020 Healthcare Conference GlobeNewswire
May-12-20 07:00AM	IGM Biosciences to Present at the 2020 RBC Capital Markets Global Healthcare Conference GlobeNewswire -8.33%
May-07-20 04:03PM	IGM Biosciences Announces First Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire +5.54%
12:25PM	Was The Smart Money Right About IGM Biosciences, Inc. (IGMS)? Insider Monkey
Apr-29-20 04:05PM	Atreca, BeiGene, and IGM Biosciences Agree to Collaborate on Novel Antibody Treatment for COVID-19 GlobeNewswire
Apr-03-20 07:00AM	IGM Biosciences to Participate in Canaccord Genuity Horizons in Oncology Virtual Event GlobeNewswire
Mar-26-20 04:05PM	IGM Biosciences Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update GlobeNewswire -9.11%
02:30PM	IGM Biosciences Inc to Host Earnings Call ACCESSWIRE
Mar-19-20 07:00AM	IGM Biosciences to Announce Fourth Quarter and Year-end 2019 Financial Results and Host Conference Call and Webcast on March 26, 2020 GlobeNewswire +26.59%
Mar-04-20 07:00AM	IGM Biosciences to Present at Two Upcoming Investor Conferences GlobeNewswire +16.14%
Feb-06-20 07:00AM	IGM Biosciences to Present at Two Upcoming Investor Conferences GlobeNewswire
Jan-07-20 07:00AM	IGM Biosciences Appoints Eric Humke, M.D., Ph.D., as Vice President, Clinical Development, Apoptosis GlobeNewswire
Dec-22-19 01:29PM	Hedge Funds Have Never Been This Bullish On IGM Biosciences, Inc. (IGMS) Insider Monkey
Nov-12-19 07:00AM	IGM Biosciences to Present at Three Upcoming Investor Conferences GlobeNewswire
Nov-07-19 05:04PM	IGM Biosciences Announces Third Quarter 2019 Financial Results GlobeNewswire
Nov-01-19 10:24AM	3 Strong Buy Stocks Jefferies Thinks Are Set to Rip Higher TipRanks

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). It is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers; and IGM-7354, an anti-PD-L1 IgM antibody for the treatment of patients with solid and hematologic malignancies; IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of patients with multiple myeloma; and IGM-2537, a bispecific T cell engaging IgM antibody targeting CD123 and CD3 proteins for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and acute lymphoblastic leukemia. It has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Topsoe Jakob Haldor	Director	May 20	Buy	16.00	1,481	23,696	73,462	May 24 05:13 PM
Keyt Bruce	Chief Scientific Officer	Apr 06	Option Exercise	0.93	2,500	2,325	42,515	Apr 08 07:24 PM
Keyt Bruce	Chief Scientific Officer	Apr 06	Sale	25.00	2,500	62,500	40,015	Apr 08 07:24 PM
LOBERG MICHAEL D	Director	Apr 01	Buy	23.00	21,739	499,997	21,739	Apr 04 08:11 PM
BEHRENS M KATHLEEN	Director	Apr 01	Buy	23.00	60,869	1,399,987	158,200	Apr 04 08:10 PM
Keyt Bruce	Chief Scientific Officer	Mar 30	Option Exercise	0.93	7,500	6,975	47,515	Apr 01 08:16 PM
Keyt Bruce	Chief Scientific Officer	Mar 30	Sale	28.50	7,500	213,725	40,015	Apr 01 08:16 PM
Keyt Bruce	Chief Scientific Officer	Nov 02	Sale	51.37	1,326	68,117	3,057	Nov 03 07:55 PM
Keyt Bruce	Chief Scientific Officer	Nov 01	Option Exercise	0.93	2,500	2,325	5,557	Nov 03 07:55 PM
Keyt Bruce	Chief Scientific Officer	Oct 05	Sale	64.10	1,242	79,617	3,057	Oct 05 09:28 PM
Keyt Bruce	Chief Scientific Officer	Oct 01	Option Exercise	0.93	2,500	2,325	5,557	Oct 05 09:28 PM
Keyt Bruce	Chief Scientific Officer	Sep 03	Sale	70.69	1,244	87,932	3,057	Sep 03 08:23 PM
Keyt Bruce	Chief Scientific Officer	Sep 01	Option Exercise	0.93	2,500	2,325	5,557	Sep 03 08:23 PM
Hambleton Julie	Director	Aug 09	Sale	80.00	1,000	80,000	2,000	Aug 11 09:37 PM
Keyt Bruce	Chief Scientific Officer	Aug 04	Sale	67.00	1,242	83,214	3,057	Aug 04 08:42 PM
Keyt Bruce	Chief Scientific Officer	Aug 02	Option Exercise	0.93	2,500	2,325	5,557	Aug 04 08:42 PM
Keyt Bruce	Chief Scientific Officer	Jul 06	Sale	82.50	1,247	102,878	3,057	Jul 06 07:46 PM
Chen Daniel ShinYu	Chief Medical Officer	Jul 06	Sale	82.75	943	78,033	116,518	Jul 06 07:45 PM
Chen Daniel ShinYu	Chief Medical Officer	Jul 01	Option Exercise	1.39	1,900	2,641	118,418	Jul 06 07:45 PM
Keyt Bruce	Chief Scientific Officer	Jul 01	Option Exercise	0.93	2,500	2,325	5,557	Jul 06 07:46 PM
Keyt Bruce	Chief Scientific Officer	Jun 02	Sale	79.15	1,245	98,542	3,057	Jun 03 08:30 PM
Chen Daniel ShinYu	Chief Medical Officer	Jun 02	Sale	79.15	941	74,480	116,518	Jun 03 08:29 PM
Chen Daniel ShinYu	Chief Medical Officer	Jun 01	Option Exercise	1.39	1,900	2,641	118,418	Jun 03 08:29 PM
Keyt Bruce	Chief Scientific Officer	Jun 01	Option Exercise	0.93	2,500	2,325	5,557	Jun 03 08:30 PM
Hambleton Julie	Director	Jun 01	Sale	80.00	2,000	160,000	3,000	Jun 03 08:29 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience